CD44 and pancreatic neoplasm: Shah et al. generated gemcitabine resistant pancreatic cancer cells presenting with an over-expression of vimentin and a reduction E-cadherin expression in combination with the detection of a CD44+CD24+EpCAM+ subpopulation [59].